Vivek Ramaswamy strikes again, this time launching a Beijing-based biotech player with a pipeline

Another day, another startup at Vivek Ramaswamy’s Roivant. And this time he’s underscoring the global nature of the industry and his business strategy, as China’s biotech scene explodes with fresh cash and some familiar drugs.